Cargando…
Correction to: Mesenchymal stem cells in the treatment of severe COVID-19
Autores principales: | Kesari, Santosh, Kasper, Gregory C., Verkh, Lev, Hammond, Terese C., Matal, Marla L., Hammerling, Jay W., Tankovich, Nikolai, Lim, Adrianus P., Zhao, Kevin H., Juarez, Tiffany, Redfern, Roberta E., Gill, Jaya M., Nomura, Natsuko, Hiemer, Audrey, Heng, Annie, Shoemaker, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381133/ https://www.ncbi.nlm.nih.gov/pubmed/34458585 http://dx.doi.org/10.1186/s41231-021-00098-x |
Ejemplares similares
-
Mesenchymal stem cells in the treatment of severe COVID-19
por: Kesari, Santosh, et al.
Publicado: (2021) -
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001
por: Hammond, Terese Catherine, et al.
Publicado: (2022) -
Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases
por: Nomura, Natsuko, et al.
Publicado: (2014) -
A Review of Persistent Post-COVID Syndrome (PPCS)
por: Oronsky, Bryan, et al.
Publicado: (2021) -
A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma
por: Yenugonda, Venkata, et al.
Publicado: (2017)